Also listed on Astex Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 10, 2042 · High confidence
20-year base term ends Oct 27, 2041
Held by Taiho Pharmaceutical Co., Ltd.
Filed Apr 26, 2023 as application 18/250,674 · Granted Aug 4, 2026
Base term plus 409 days of patent term adjustment (USPTO delay)
Today
2021
2042
Clock starts
Oct 27, 2021
Oct 27, 2021
Term ends
Dec 10, 2042
Dec 10, 2042
Granted
Aug 4, 2026
Aug 4, 2026
base term
patent term adjustment
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
409
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
26
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 409 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 27, 2021, when application PCT/US2021/056809, the earliest non-provisional in its chain, was filed (this one was filed Apr 26, 2023) | Oct 27, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +409 days, USPTO patent term adjustment record | Dec 10, 2042 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 10, 2042 | High confidence |
This family
| US 6,613,753 | Term ended Mar 2021 | Mar 2021 |
| US 8,324,180 | In force Jul 2030 | Jul 2030 |
| US 8,329,665 | In force Jul 2030 | Jul 2030 |
| US 8,329,666 | In force Jul 2030 | Jul 2030 |
| US 8,609,631 | In force Apr 2030 | Apr 2030 |
| US 9,040,501 | In force Apr 2030 | Apr 2030 |
| Application PCT/US2014/062874 | PCT application no patent term | no patent term |
| US 9,834,576 | In force Oct 2034 | Oct 2034 |
8 of 26 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 6, 2023 Reel 64168, frame 926 | Dao, Kim-hien; Keer, Harold; Oganesian, Aram | Astex Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 6, 2023 Reel 64168, frame 936 | Astex Pharmaceuticals, Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Dec 4, 2025 Reel 73115, frame 640 | Otsuka Pharmaceutical Co., Ltd. | Taiho Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2042
Term ends Dec 10, 2042. Maintenance fees still fall due before then
Note
The 409 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.